BioImagene adds Siemens funding for digital pathology
Digital pathology developer BioImagene brought Siemens Venture Capital into its fold last week, adding an unreleased amount to a recently-closed $26 million fourth-round of financing. That round was led by Burill & Co. and included Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.
The Cupertino, Calif.-based company helps laboratories view, manage and analyze images of pathologies. It provides tools to turn microscope slides into high-resolution images that can then be shared and transferred… Continue Reading
Life sciences briefing: Monday, Dec. 3, 2007
Featured companies: CoMentis, ForHealth Technologies, Merrimack Pharmaceuticals, QuantomiX, Progenitor Cell Therapy, River Diagnostics, Topaz Pharmaceuticals
UPDATED: Expanded items on CoMentis, Topaz and ForHealth.
CoMentis gets $12M for eye, Alzheimer’s treatments — South San Francisco’s CoMentis, a biotech pursuing treatments for Alzheimer’s disease and macular degeneration, raised $12 million in a third funding round, VentureWire reports (subscription required). Wellington Management provided the funding.
The company’s lead drug candidate, ATG003, is an eye drop designed to treat age-related macular degeneration (AMD), a… Continue Reading
Life sciences briefing: Thursday, Sept. 13, 2007
Featured companies: Aldagen, LDR, Lyten Endoscopy, MachLabs, Permatox, TeleMedicine Clinic, ThromboVision
Spinal-implant maker LDR raises $25M — Austin, Texas-based LDR, a maker of spinal implants, raised $25 million in a third funding round. Investors included Telegraph Hill Partners, Austin Ventures, Rothschild Private Equity and PTV Sciences.
LDR sells spinal-fusion devices, artificial disks and other spine-related devices in more than 30 countries, and plans to use the funds for further expansion.
Aldagen adds $9M for adult stem-cell work — Aldagen,… Continue Reading